Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Xin-Rong Yang

Showing results (21-30 of 116) with videos related to

Pageof 12
Sort By:
Hepatology (Baltimore, Md.)|November 24, 2012
Circulating stem cell-like epithelial cell adhesion molecule-positive tumor cells indicate poor prognosis of hepatocellular carcinoma after curative resectionYun-Fan Sun, Yang Xu, Xin-Rong Yang, et al.
Cancer Letters|June 11, 2019
MDM2-NFAT1 dual inhibitor, MA242: Effective against hepatocellular carcinoma, independent of p53Wei Wang, Jian-Wen Cheng, Jiang-Jiang Qin, et al.
Plos One|January 26, 2013
Prognostic significance of Capn4 overexpression in intrahepatic cholangiocarcinomaChi Zhang, Dou-Sheng Bai, Xiao-Yong Huang, et al.
European Radiology|August 21, 2012
Visualising liver fibrosis by phase-contrast X-ray imaging in common bile duct ligated miceXi Zhang, Xin-Rong Yang, Yu Chen, et al.
Hepatobiliary & Pancreatic Diseases International : HBPD INT|October 13, 2012
Sorafenib in treatment of patients with advanced hepatocellular carcinoma: a systematic reviewXin Zhang, Xin-Rong Yang, Xiao-Wu Huang, et al.
American Journal of Cancer Research|January 10, 2018
Low <i>SLC29A1</i> expression is associated with poor prognosis in patients with hepatocellular carcinomaPing-Ting Gao, Jian-Wen Cheng, Zi-Jun Gong, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 2, 2014
Systemic immune-inflammation index predicts prognosis of patients after curative resection for hepatocellular carcinomaBo Hu, Xin-Rong Yang, Yang Xu, et al.
Science Bulletin|December 22, 2022
Fluorescent probes for the detection of disease-associated biomarkersWei-Tao Dou, Hai-Hao Han, Adam C Sedgwick, et al.
Cell Death & Disease|July 26, 2020
Anlotinib suppresses tumor progression via blocking the VEGFR2/PI3K/AKT cascade in intrahepatic cholangiocarcinomaFei Song, Bo Hu, Jian-Wen Cheng, et al.
Journal of Gastrointestinal Oncology|January 12, 2026
Revisiting the role of postoperative adjuvant transarterial chemoembolization in hepatocellular carcinoma: a propensity score matching analysisJia-Jun Li, Ye Xu, Hua-Hua Liu, et al.
Pageof 12

Showing results (21-30 of 116) with videos related to

Sort By:
Pageof 12
Hepatology (Baltimore, Md.)|November 24, 2012
Circulating stem cell-like epithelial cell adhesion molecule-positive tumor cells indicate poor prognosis of hepatocellular carcinoma after curative resectionYun-Fan Sun, Yang Xu, Xin-Rong Yang, et al.
Cancer Letters|June 11, 2019
MDM2-NFAT1 dual inhibitor, MA242: Effective against hepatocellular carcinoma, independent of p53Wei Wang, Jian-Wen Cheng, Jiang-Jiang Qin, et al.
Plos One|January 26, 2013
Prognostic significance of Capn4 overexpression in intrahepatic cholangiocarcinomaChi Zhang, Dou-Sheng Bai, Xiao-Yong Huang, et al.
European Radiology|August 21, 2012
Visualising liver fibrosis by phase-contrast X-ray imaging in common bile duct ligated miceXi Zhang, Xin-Rong Yang, Yu Chen, et al.
Hepatobiliary & Pancreatic Diseases International : HBPD INT|October 13, 2012
Sorafenib in treatment of patients with advanced hepatocellular carcinoma: a systematic reviewXin Zhang, Xin-Rong Yang, Xiao-Wu Huang, et al.
American Journal of Cancer Research|January 10, 2018
Low <i>SLC29A1</i> expression is associated with poor prognosis in patients with hepatocellular carcinomaPing-Ting Gao, Jian-Wen Cheng, Zi-Jun Gong, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 2, 2014
Systemic immune-inflammation index predicts prognosis of patients after curative resection for hepatocellular carcinomaBo Hu, Xin-Rong Yang, Yang Xu, et al.
Science Bulletin|December 22, 2022
Fluorescent probes for the detection of disease-associated biomarkersWei-Tao Dou, Hai-Hao Han, Adam C Sedgwick, et al.
Cell Death & Disease|July 26, 2020
Anlotinib suppresses tumor progression via blocking the VEGFR2/PI3K/AKT cascade in intrahepatic cholangiocarcinomaFei Song, Bo Hu, Jian-Wen Cheng, et al.
Journal of Gastrointestinal Oncology|January 12, 2026
Revisiting the role of postoperative adjuvant transarterial chemoembolization in hepatocellular carcinoma: a propensity score matching analysisJia-Jun Li, Ye Xu, Hua-Hua Liu, et al.
Pageof 12